FindTrial
Sign In

Compare Empagliflozin and Dapagliflozin in Type 2 Diabetes patients taking Metformin

A Comparison of the effectiveness and safety of Empagliflozin and Dapagliflozin in type 2 Diabetes mellites patients already on Metformin - A Prospective Comparative study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100810
Enrollment
80
Registered
2026-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: A Comparison of the effectiveness and safety: A Comparison of the effectiveness and safety of Empagliflozin and Dapagliflozin in type 2 DM Patients already on metformin Intervention2:

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: around 40 to 75 years of age with both sexes

Exclusion criteria

Exclusion criteria: Type I diabetes Mellitus

Design outcomes

Primary

MeasureTime frame
changes in blood glucose levelTimepoint: 1 year—

Secondary

MeasureTime frame
changes in HbA1CTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Naveen V

Vinayaka Missions Kirupananda Variyar Medical College and Hospital

drvsivasankari@gmail.com9443515035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026